DOREA DIMAGGIO: Open Payments
NPI 1679172894 · FREEHOLD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$500 in 20 payments from 7 companies in 2025. Trend: 2023 $489 · 2024 $444 · 2025 $500
Food & beverage: $500
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $208 |
| GENZYME CORPORATION | 1 | $120 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $90 |
| Janssen Biotech, Inc. | 2 | $34 |
| Organon LLC | 1 | $17 |
| UCB, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
Products named: RINVOQ, DUPIXENT, ILUMYA, TREMFYA, SKYRIZI, VTAMA, Bimzelx, TALTZ.
Industry payments across NJ — which companies pay providers there.
